Product Details
Synonyms
A1S9T and BN75 temperature sensitivity complementing, A1S9T, A1ST, AMCX1, GXP1, MGC4781, POC20 centriolar protein homolog, POC20, Protein A1S9, SMAX2, UBA1, UBA1, ubiquitin-activating enzyme E1 homolog A, UBA1A, UBE1, UBE1A1S9, UBE1X, ubiquitin-activating enzyme E1 (A1S9T and BN75 temperature sensitivitycomplementing), Ubiquitin-activating enzyme E1, Ubiquitinactivating Enzyme, Ubiquitin-activating Enzyme, ubiquitin-like modifier activating enzyme 1, ubiquitin-like modifier-activating enzyme 1
Source
Human UBE1/UBA1, His Tag (UB1-H5248) is expressed from Baculovirus-Insect cells. It contains AA Ser 2- Arg 1058 (Accession # P22314-1).
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the N-terminus.
The protein has a calculated MW of 119.8 kDa. The protein migrates as 120-130 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
Formulation
Supplied as 0.2 μm filtered solution in 20 mM Tris, 150 mM NaCl, pH7.5 with glycerol as protectant.
Contact us for customized product form or formulation.
Shipping
This product is supplied and shipped with dry ice, please inquire the shipping cost.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Human UBE1/UBA1, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
SEC-MALS

The purity of Human UBE1/UBA1, His Tag (Cat. No. UB1-H5248) is more than 85% and the molecular weight of this protein is around 115-135 kDa verified by SEC-MALS.
Report
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Ubiquitin-like modifier-activating enzyme 1
- Category:
- Approved Drugs:
0 Details
- Drugs in Clinical Trials:
1 Details
- Highest Development Stage:
Phase 1 Clinical
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















